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to deteriorate slowly, but a large individual variation in the course of pain
is seen over time. Yet, there is a paucity of data on the course of pain in
patients with OA. More information on the course of pain is important
for clinicians to optimize treatment for patients with OA. Therefore, the
aim of this study is to detect different longitudinal trajectories of patients
with hip pain due to OA measured with a visual analogue scale (VAS) in
a two-year follow-up cohort study.
Methods: The current study investigated the course of pain of
222 patients with clinically and radiographic determined hip OA. Patients
ﬁlled out nine questionnaires every three months during the follow-up
period of two years. Pain was measured by VAS (0–100) and categorized
as mild (<30), moderate (≥30), and severe (≥54) pain. Latent class growth
analysis (LCGA) was used to determine the number of trajectories of
patients with hip pain due to OA.
Results: Analyses yielded 5 trajectories of pain due to hip OA. Patients
within trajectory 1 (“mild pain”; n = 69) had stable, mild levels of pain
(range: 7.3 to 16.3). Patients in trajectory 2 (“moderate pain”; n = 31)
reported moderate levels of pain which ﬂuctuated slightly during the
follow-up period of two years (range 42.3 to 58.4). The third trajectory
(“always painful”; n = 32) consists of patients that had severe levels
of pain (range: 65.9 to 76.3). Patients within trajectory 4 (“regularly
increasing”; n =48) started with mild levels of pain (mean VAS: 22.2)
and progressed slowly to moderate levels of pain after two years of
follow-up (mean VAS: 37.4). Trajectory 5 (“highly progressing”; n = 42)
also started with mild levels of pain at baseline (mean VAS 25.7), but
progressed quickly to severe levels of pain after two years (mean VAS:
59.4). Patients identiﬁed as “always painful” and “highly progressing”
had, compared with the other trajectories, more severe radiographic hip
OA and a longer duration of complaints.
Conclusions: LCGA has been applied to longitudinal data of patients
with hip OA and identiﬁed 5 distinct patient groups (based on reported
pain severity) which will improve the understanding of the course of OA
pain. Additional research will be conducted to externally reproduce these
ﬁndings and to determine the association of these trajectory classes with
demographic and disease-speciﬁc characteristics. Furthermore, clinicians
and researchers may need to consider and investigate whether these 5
subgroups of patients may need different types of management.
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THE ASSOCIATIONS BETWEEN LOW BACK PAIN, MORNING STIFFNESS
AND LUMBAR DISC DEGENERATION: A ROTTERDAM STUDY
J. Scheele, E.I. de Schepper, P.A. Luijsterburg, A. Hofman, B.W. Koes,
S.M. Bierma-Zeinstra. Erasmus MC, Univ. Med. Ctr., Rotterdam, Netherlands
Purpose: Morning stiffness is an important symptom and clinical
classiﬁcation criterion for hip and knee osteoarthritis (OA). However,
it is still unknown if there is a similar relation in the spine and if such a
symptom can be used for sub-grouping back pain patients. Therefore, the
aim of this study is to explore the associations between spinal morning
stiffness and lumbar disc degeneration (LDD), and to compare these
associations with the associations between morning stiffness in the legs
and radiographic knee and hip OA.
Methods: We analyzed data from the Rotterdam Study, an open
population prospective cohort study of people aged ≥ 55 years.
The intervertebral disc spaces (L1/L2 to L4/L5) and osteophytes were
scored on a lumbar lateral radiograph using a 3-grade scale. We used
two different deﬁnitions for LDD: 1) disc space narrowing (grade ≥1)
on 2 or more levels, further referred as “narrowing”, and 2) presence
of osteophytes (grade ≥2) on 2 or more levels, further referred as
“osteophytes”. Logistic regression analysis was used to explore the
associations between morning stiffness in the spine and the two
deﬁnitions of LDD. Also analysed was low back pain combined with
spinal morning stiffness and its association with LDD. Similar analyses
were performed for knee and hip pain, morning stiffness in the legs, and
radiographic knee and hip OA (K&L grade ≥2). All analyses were adjusted
for age, gender, and Body Mass Index (BMI).
Results: Lumbar radiographs were scored for all 2819 adults. “Narrowing”
was present in 525 adults (18.6%). “Osteophytes” was present in 839
adults (29.8%). 17.7% of the adults reported low back pain during the last
month. Morning stiffness in the spine was reported by 8.8% of the total
population.
The LDD deﬁned as “narrowing” was associated with spinal morning
stiffness (OR 1.8; 95%CI: 1.4–2.2), and with the combination of low back
pain and spinal morning stiffness (OR 2.8; 95%CI: 2.0–3.8).
The associations between “osteophytes” and spinal morning stiffness
was OR 1.3 (95% CI: 1.1–1.6) and OR 1.6 (95% CI:1.2–2.1) if we combined
low back pain with spinal morning stiffness.
Knee radiographs were made for 2643 adults, and hip radiographs for
2760 adults.
The associations between radiographic knee OA and morning stiffness
in the legs was OR1.2 (95% CI:0.9–1.6). If knee pain was combined with
morning stiffness, the association was OR 3.1 (95% CI:2.1–4.6).
For radiographic hip OA and the associations with morning stiffness in
the legs or hip pain combined with morning stiffness were OR1.1 (95%
CI:0.7–1.7) and OR 2.5 (95% CI:1.3–4.8) respectively.
Conclusions: There is a moderate association between reported spinal
morning stiffness and both deﬁnitions of LDD. However, the deﬁnition
“narrowing” was stronger associated with morning stiffness. The
associations are higher than the associations seen in knee and hip OA.
The associations between LDD and low back pain in combination with
spinal morning stiffness are comparable with the associations of knee
and hip OA. Therefore, morning stiffness might be one of the symptoms
to subgroup non-speciﬁc low back pain patients with respect to low back
degeneration.
There were a few limitations to this study: morning stiffness used in the
analysis for knee and hip OA is only speciﬁed as morning stiffness in the
legs and only lateral radiographs of the lumbar spine were assessed.
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ASSOCIATION BETWEEN SEVERE PAIN IN THE EARLY MONTHS
FOLLOWING TOTAL KNEE REPLACEMENT AND FUNCTIONAL
OUTCOMES OVER FIVE YEAR FOLLOW-UP
J.N. Katz1, E.A. Wright1, E.A. Lingard2, E. Losina1. 1Brigham and Women’s
Hosp., Boston, MA, USA; 2Registrar in Publ. Hlth., Newcastle upon Tyne,
United Kingdom
Purpose: Over 600,000 total knee replacements are performed annually
in the US at present and the rate is increasing rapidly. Severe pain persists
following surgery in >15% of TKR recipients. The health and economic
consequences of the syndrome of persistent pain following TKR have not
been examined.
Methods: We analyzed data from a multicenter prospective cohort of
860 TKR recipients from referral centers in the US, United Kingdom
and Australia. Patients were evaluated with self-report measures of pain
and function preoperatively and at 3 months and one, two and ﬁve
years postoperatively. Patients also reported on utilization of health
care provider services. We examined the associations between having
a WOMAC pain score in the lowest 15% of the cohort three months
following surgery and a range of symptomatic, functional and resource
utilization outcomes at one, two and ﬁve years postoperatively.
Table: Associations between severe pain at three months and outcomes
at one, two and ﬁve year follow up.
Outcomes at follow-up WOMAC Pain in lowest 15% at 3 months
One year
f/u
Two year
f/u
Five year
f/u
Yes No Yes No Yes No
Can’t walk 5 blocks 66% 40% 65% 41% 60% 35%
Dissatisﬁed with TKR 25% 6% 26% 4% 24% 6%
Mean WOMAC function* 55 76 56 77 59 80
Mean WOMAC pain* 62 86 65 87 64 86
PT visit for knee problem 44% 28% 23% 9% NA NA
*WOMAC scores 0 = worst, 100 = best.
P-values <0.001 for all contrasts between ‘Yes’ and ‘No’ within each
cohort.
NA = not assessed.
Results: The mean age of cohort members at surgery was 70 and 59%
were female. 15% of patients had WOMAC pain scores worse than 50
at three months (on a scale of 0–100 with 100 = best score). These
subjects were much more likely than subjects with better pain scores at
3 months to report being unable to walk 5 blocks and to be dissatisﬁed
with surgery. They also had much (21–24 points) worse WOMAC function
and pain scores, on average, at one, two and ﬁve year follow-up (Table).
Patients with persistent pain 3 months after TKR were also more likely
than subjects with less severe pain at 3 months to be seeing a physical
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therapist for their knee at one and two years (Table). All of these contrasts
were highly statistically signiﬁcant (p < 0.001).
Conclusions: TKR recipients with severe knee pain in the early
months following surgery have much greater functional deﬁcits and
dissatisfaction with the results of surgery at one, two and ﬁve
year follow-up than patients with less severe pain in the early
months following TKR. These data highlight the health and economic
consequences of severe, persistent pain following TKR. The ﬁndings
underscore the potential value of optmimizing patient selection and
of identifying patients at risk and implementing interventions to reduce
the frequency of severe pain in the early months following TKR.
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IMPACT OF EXERCISE TYPE AND DOSE ON PAIN IN KNEE
OSTEOARTHRITIS: A SYSTEMATIC REVIEW AND META-REGRESSION
ANALYSIS
C. Juhl1,2, R. Christensen1,3, E.M. Roos1, W. Zhang4, H. Lund1. 1Res. Unit
for Musculoskeletal Function and Physiotherapy, Odense, Denmark; 2Dept.
of Physiotherapy, Gentofte Hosp., Copenhagen, Denmark; 3The Parker Inst.:
Musculoskeletal Statistics Unit, Copenhagen Univ. Hosp., Frederiksberg,
Denmark; 4Academic Rheumatology, Univ. of Nottingham, Nottingham,
United Kingdom
Purpose: To analyze the effect of published exercise therapy programs
aimed at reducing pain in patients with osteoarthritis (OA) in the knee,
in order to identify the most optimal exercise program characterized
by number of supervised sessions, type of exercise, relative exercise
intensity and duration of exercise sessions.
Methods: A systematic review and meta-analysis based on published
exercise studies identiﬁed by a comprehensive literature was performed.
Eligible were randomized controlled trials comparing any exercise
intervention with a sham or non-intervention control in patients with
knee OA, using a least one patient reported outcome on pain. Effect sizes
were calculated as standardized mean differences (SMD) estimated from
differences in mean changes between intervention- and control group
after an exercise program, divided by the pooled standard deviation.
SMDs were combined by using a random effects meta-analysis model;
incl. both 95% conﬁdence intervals and prediction intervals. Stratiﬁed
analyses and meta-regression analyses were used to examine study-level
covariates.
Results: Forty one trials with 3274 patients with knee OA comparing 48
interventions with controls were included in the analyses. The pooled
SMD for the reduction of pain was 0.48 [95% CI: 0.36; 0.60] in favor
of exercise, although based on a large between study inconsistency
(I2= 58%). Interpreting this heterogeneity, the 95% prediction interval
(−0.14; 1.10) contains values below 0 and so, although on average the
intervention seems effective, it may not always be beneﬁcial in an
individual setting.
Focusing on pain in pre-speciﬁed stratiﬁed analyses showed almost
similar effects for programs aiming at improving muscle strength, aerobic
capacity or functional performance (SMD[pain]: 0.56, 0.67, and 0.49,
respectively, P = 0.822; pooled SMD= 0.57 [95% CI: 0.44; 0.69], I2= 53%).
Whereas combined programs were less effective in reducing pain (SMD
[pain]: 0.14 [95%CI: −0.11; 0.40], I2=58%), with a statistically signiﬁcant
difference (P < 0.001) between exercise subgroups SMD= 0.43 [95% CI:
0.31; 0.54] in favor of using only one type of exercise.
Heterogeneity in aerobic exercise trials could be explained in a meta-
regression model using numbers of supervised sessions. The reduction
of pain (beta-coefﬁcient = 0.026, [95% CI: 0.01–0.05], I2=23%), was
signiﬁcantly increased with a larger number of supervised exercise
sessions. In resistance exercise heterogeneity could not be explained by
study-level covariates. Stratiﬁed analyses for pain showed larger effect
when focusing on quadriceps strengthening only compared to lower limb
strengthening or strengthening the whole body (SMD[pain]: 0.72, 0.42
respectively, P = 0.04).
Conclusions: Exercise programs have on average a moderate effect for
reducing pain in knee osteoarthritis trials. However, inconsistency across
studies suggests that it will not always imply beneﬁt in comparison
with a matched control group. Stratiﬁed analyses provide evidence that
exercise programs aiming at improving strength, aerobic capacity or
functional performance are more efﬁcacious than combined exercise
programs. While the number of supervised sessions may enhance the
beneﬁts of the aerobic exercise, focusing on the quadriceps only, may
increase beneﬁts of resistance training.
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THE ARCOGEN GENOME-WIDE ASSOCIATION STUDY
K. Panoutsopoulou, on behalf of the arcOGEN Consortium and the
replication studies. Wellcome Trust Sanger Inst., Hinxton, United Kingdom
Purpose: To enable a well-powered genome-wide association study
(GWAS) for osteoarthritis (OA), we have formed the arcOGEN Consortium,
a UK-wide collaboration, and have carried out the largest GWAS to date
in 7,410 knee and/or hip OA cases and 11,009 controls.
Methods: OA cases were ascertained based on radiographic evidence of
disease (Kellgren-Lawrence grade ≥2) or clinical evidence of disease to
a level requiring total joint replacement (TJR) and were genotyped on
the Illumina Human610 platform. The study used two different types
of controls: 11,009 population-based, unrelated UK controls which came
from 5 distinct sources (the 1958 Birth Cohort and the UK Blood Donor
Service from the Wellcome Trust Case Control Consortium 2 study, the
1958 Birth Cohort from the T1DGC study, the ALSPAC study and the PoBI
study) genotyped on a variety of Illumina platforms; and 1,828 unrelated,
disease-free controls from the TwinsUK cohort (females only) genotyped
on the Illumina Human610 platform. Analyses were also performed
stratifying the cases by severity, i.e., total joint replacement (TJR) and
by joint and gender. We took forward 129 signals with p < 10−5 and
good quality control properties for in silico replication in 5 other GWAS
(deCODE, EGCUT, GARP, Rotterdam RS1 and RS2 cohorts, and TwinsUK
comprising a total of 5,064 cases and 40,619 controls) and based on these
results we prioritized 26 SNPs with p < 5×10−6 for de novo replication in
2,409 additional arcOGEN cases and 2,319 population-based controls.
Results: Following large-scale replication we have identiﬁed 5 loci
to be associated with OA at the genome-wide signiﬁcance threshold
(p < 5×10−8). The most highly associated SNP, rs6976 in the TJR analysis
(OR for the T allele = 1.12 [1.08–1.16] p =7.2×10−11) is located in
chr3p21.1, a gene-rich region. Three other genome-wide signiﬁcant
signals (rs4836732, rs9350591 and rs10492367) lie in regions/genes
with no apparent role in OA, while rs835487 (association of G allele
with total hip replacement: OR= 1.13 [1.09–1.18] p =1.6×10−8) is located in
intron 2 of the chondroitin 4 sulfotransferase 11, involved in chondrocyte
development during cartilage morphogenesis. We also report association
of rs8044769 at the FTO locus with OA in females, p = 6.85×10−8. It
appears that the FTO SNP exerts its effect on OA through obesity since
the signal is attenuated after adjustment for BMI.
Conclusions: We have identiﬁed ﬁve novel OA loci conferring modest
risk for OA. Functional studies will be needed to identify the underlying
causative genes and understand their involvement in the aetiology
of OA.
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ANALYSIS OF CANDIDATE OSTEOARTHRITIS GENES IN A
META-ANALYSIS OF 8 GENOME-WIDE ASSOCIATION STUDIES
C. Rodriguez-Fontela1, E. Evangelou2, A. Valdes3, M. Calaza1, The
arcOGEN Consortium, N.K. Arden4, S. Bos5, A. Cupples6, T. Esko7,
J. Gomez-Reino1, H. Helgadottir8, A. Hofman9,10, I. Jonsdottir8,
H.J.M. Kerkhof9,10, I. Meulenbelt5,10, S. Metrustry3, A. Metspalu7,
J. van Meurs9, E. Ntzani2, K. Panoutsopoulou4, U. Styrkarsdottir8,
U. Thorsteinsdottir8, G. Thorleifsson8, Y. Zhu6, D. Felson6, J. Ioannidis2,
K. Stefansson8, A. Uitterlinden9,10, E. Zeggini4, T. Spector3, A. Gonzalez1.
1Hosp. Clinico Univ.rio de Santiago, Santiago de Compostela, Spain; 2Dept.
of Hygiene and Epidemiology, University of Ioannina School of Medicine,
Ioannina, Greece; 3Dept of Twin Res. and Genetic Epidemiology, St. Thomas’
Hospital, King’s College London, United Kingdom; 4arcOGEN Consortium,
Hinxton, United Kingdom; 5Section of Molecular Epidemiology, Leiden
University Medical Centre, Leiden, Netherlands; 6Dept. of Biostatistics,
Boston University School of Public Health, Boston, MA, USA; 7Estonian
Genome Ctr., University of Tartu, Tartu, Estonia; 8deCODE Genetics,
Reykjavik, Iceland; 9Dept. of Internal Med., Erasmus Medical Center,
Rotterdam, Netherlands; 10The Netherlands Genomics Initiative-Sponsored
Netherlands Consortium for Hlth.y Aging, Rotterdam, Netherlands
Purpose: We aimed to assess OA susceptibility candidate genes deﬁned
according to previous genetic research in a metaanalysis of 8 genome-
wide association scans (GWAS) performed in subjects of European
ancestry.
Methods: OA susceptibility candidate genes were identiﬁed under the
OA, spinal osteophytosis and invertebral disk displacement phenotypes
in HuGE Navigator, which is a continuously updated knowledge base
in human genome epidemiology. Map positions of loci encompassing
